Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis
Open accessThe DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
The role of the mesenchymal stromal cell- (MSC-) derived secretome is becoming increasingly intriguing from a clinical perspective due to its ability to stimulate endogenous tissue repair processes as well as its effective regulation of the immune system, mimicking the therapeutic effects produced by the MSCs. The secretome is a composite product secreted by MSC in vitro (in conditioned medium) and in vivo (in the extracellular milieu), consisting of a protein soluble fraction (mostly growth factors and cytokines) and a vesicular component, extracellular vesicles (EVs), which transfer proteins, lipids, and genetic material. MSC-derived secretome differs based on the tissue from which the MSCs are isolated and under specific conditions (e.g., preconditioning or priming) suggesting that clinical applications should be tailored by choosing the tissue of origin and a priming regimen to specifically correct a given pathology. MSC-derived secretome mediates beneficial angiogenic effects in a variety of tissue injury-related diseases. This supports the current effort to develop cell-free therapeutic products that bring both clinical benefits (reduced immunogenicity, persistence in vivo , and no genotoxicity associated with long-term cell cultures) and manufacturing advantages (reduced costs, availability of large quantities of off-the-shelf products, and lower regulatory burden). In the present review, we aim to give a comprehensive picture of the numerous components of the secretome produced by MSCs derived from the most common tissue sources for clinical use (e.g., AT, BM, and CB). We focus on the factors involved in the complex regulation of angiogenic processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The overall presence and concentration of angiogenic factors within the CM were found to be superior in BM preparations with increased relative levels of tubulogenesis-driving factors such as VEGF [39, 40].”
From Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach (2023) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gong, X., Liu, H., Wang, S., Liang, S., & Wang, G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28070 · Cited by 140
RetractedMultilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 2×
“To differentiate MSCs from other morphologically similar cells, the International Society for Cellular Therapy (ISCT) defined the minimal set of criteria by which MSCs are identified: adherence to plastic under normal cell culture conditions; differentiation capability into multiple cell lineages including, and not li…”
BackgroundThéry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 1×
“quality/purity of isolated EVs in order to confidently report biological cargo or functions to EVs [38].”
BackgroundCaplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186 · cited 2×
“Cells secrete a wide range of EVs that differ in size, origin, content, and function [37].”
BackgroundMesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746 · cited 1×
“As an example, MSCs can differentiate into endotheliocytes and myocytes in the mesoderm under conditional induction [84].”
BackgroundCommunication by Extracellular Vesicles: Where We Are and Where We Need to Go
Tkach, M., & Théry, C. (2016) · Cell · doi:10.1016/j.cell.2016.01.043 · Cited by 3,444 · cited 2×
“Recently, it has become apparent that secreted EVs are proficient intercellular communication mediators through the transfer of their cargo to target cells and their ability to influence the behavior of recipient cells [36].”
BackgroundMesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992 · cited 1×
“While it was initially conceived that MSCs exerted their therapeutic effects by migrating to targeted sites of injury and actively contributed to tissue repair and regeneration, it is now increasingly acknowledged that MSCs do not typically engraft after transplantation, due to the phenomena of lung sequestration and…”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“Mesenchymal stromal cells (MSCs) were described for the first time in 1970 by Alexander Friedenstein as a “population of bone marrow stromal cells capable of mesodermal differentiation and trophic support of hematopoiesis” [1, 2].”
Background
Cited by
Chronic Diabetic Wounds and Their Treatment with Skin Substitutes
Holl, J., Kowalewski, C., Zimek, Z., Fiedor, P., Kaminski, A., Oldak, T., Moniuszko, M., & Eljaszewicz, A. (2021) · Cells · doi:10.3390/cells10030655 · Cited by 351
“This strong regenerative effect is associated primarily with MSC ability to improve neovascularization of the wound via paracrine activity in addition to their well-characterized anti-inflammatory effects [113].”
BackgroundGalderisi, U., Peluso, G., & Di Bernardo, G. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10231-w · Cited by 240
Miceli, V., Bulati, M., Iannolo, G., Zito, G., Gallo, A., & Conaldi, P. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020763 · Cited by 175
“MSC effects depend both on tissue source [30,31] and on how they are produced and administered.”
BackgroundAlvites, R., Branquinho, M., Sousa, A. C., Lopes, B., Sousa, P., & Maurício, A. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020381 · Cited by 174
“This fact reveals that, in addition to their ability to influence neighboring cells and tissues through a cell-to-cell interaction, MSCs also act through a paracrine signaling mechanism [132].”
BackgroundRecent advances to enhance the immunomodulatory potential of mesenchymal stem cells
Sarsenova, M., Kim, Y., Raziyeva, K., Kazybay, B., Ogay, V. B., & Saparov, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010399 · Cited by 136
Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy
Zhang, F., Guo, J., Zhang, Z., Qian, Y., Wang, G., Duan, M., Zhao, H., Yang, Z., & Jiang, X. (2022) · Cancer Letters · doi:10.1016/j.canlet.2021.11.015 · Cited by 127
The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration
Harrell, C. R., Djonov, V., & Volarević, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052472 · Cited by 124
“MSCs promote the growth of endothelial cells and induce vascular sprouting in a VEGF-dependent manner [24], while M2 macrophage-derived IL-8 induces the increased expression of VEGFR on endothelial cells, enhancing the pro-angiogenic effects elicited by MSC-sourced VEGF [19].”
BackgroundGiovannelli, L., Bari, E., Jommi, C., Tartara, F., Armocida, D., Garbossa, D., Cofano, F., Torre, M. L., & Segale, L. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.013 · Cited by 102
Chen, L., Qu, J., Mei, Q., Chen, X., Fang, Y., Chen, L., Li, Y., & Xiang, C. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02511-6 · Cited by 98
Microglia and Macrophages in Neuroprotection, Neurogenesis, and Emerging Therapies for Stroke
Var, S. R., Shetty, A. V., Grande, A. W., Low, W. C., & Cheeran, M. C. ‐. (2021) · Cells · doi:10.3390/cells10123555 · Cited by 90
Native and Bioengineered Exosomes for Ischemic Stroke Therapy
Khan, H., Pan, J.-J., Li, Y., Zhang, Z., & Yang, G.-Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.619565 · Cited by 76
Recent Advances on Cell-Based Co-Culture Strategies for Prevascularization in Tissue Engineering
Shafiee, S., Shariatzadeh, S., Zafari, A., Majd, A., & Niknejad, H. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.745314 · Cited by 90
Molnar, V., Pavelić, E., Vrdoljak, K., Čemerin, M., Klarić, E., Matišić, V., Bjelica, R., Brlek, P., Kovačić, I., Tremolada, C., et al. (2022) · Genes · doi:10.3390/genes13060949 · Cited by 90
Jahangiri, B., Khalaj‐Kondori, M., Asadollahi, E., Dizaj, L. P., & Sadeghizadeh, M. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122214 · Cited by 81
Munoz-Perez, E., Gonzalez‐Pujana, A., Igartúa, M., Santos‐Vizcaíno, E., & Hernández, R. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111802 · Cited by 85
“Because of these issues—and taking into account that the secretory effects of MSCs are considered the main factor responsible for their therapeutic properties [27,28]—the attention has now shifted to the MSC-derived secretome, which will be deeply reviewed in Section 2.”
BackgroundAutophagy in the Regulation of Tissue Differentiation and Homeostasis
Perrotta, C., Cattaneo, M. G., Molteni, R., & Palma, C. D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602901 · Cited by 79
“…demonstrated to be central in all these cells, as it modulates cell signaling and metabolism, antigen presentation, proteostasis, mitochondrial function and reactive oxygen species (ROS) production and ER stress (Rathmell, 2012; Gkikas et al., 2018; Smith, 2018; Valecka et al., 2018; Macian, 2019).”
BackgroundRitter, A., Kreis, N., Hoock, S. C., Solbach, C., Louwen, F., & Yuan, J. (2022) · Cancers · doi:10.3390/cancers14163908 · Cited by 72
Kuppa, S. S., Kim, H. K., Kang, J. Y., Lee, S. C., & Seon, J. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113016 · Cited by 67
Generation of Cortical Brain Organoid with Vascularization by Assembling with Vascular Spheroid
Kook, M. G., Lee, S., Shin, N., Kong, D., Kim, D., Kim, M., Kang, H. K., Choi, S. W., & Kang, K. (2022) · International Journal of Stem Cells · doi:10.15283/ijsc21157 · Cited by 68
“In particular, hUCB-MSCs can enhance angiogenesis, producing proangiogenic cytokines and growth factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factors (bFGF), which promote EC proliferation and vascularization (25-27).”
The Potential of MSC-Based Cell-Free Therapy in Wound Healing—A Thorough Literature Review
Ma, H., Siu, W. S., & Leung, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119356 · Cited by 67
“It was reported that compared with bone m rrow-derived MSC , MSC derived from adult tissue released igher l vel of angiogenic factors, such as VEGF, insulin-like growth f ctor 1 (IGF-1), IL-8, a d MMP3, exhibited a stronger pro-angiogenetic ability [67].”
ResultChen, W., Xie, G., Lu, Y., Wang, J., Feng, B., Wang, Q., Xu, K., & Bao, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121260 · Cited by 58
Pharoun, J., Berro, J., Sobh, J., Abou-Younes, M.-M., Nasr, L., Majed, A., Khalil, A., Joseph, J., Stephan, & Faour, W. H. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176719 · Cited by 59
Zhang, L., Graf, I., Kuang, Y., Zheng, X., Haupt, M., Majid, A., Kılıç, E., Hermann, D. M., Psychogios, M., Weber, M. S., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315031 · Cited by 63
Nammian, P., Asadi-Yousefabad, S.-L., Daneshi, S., Sheikhha, M. H., Tabei, K., & Razban, V. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02110-x · Cited by 61
“On the other hand, one of the most important property of MSCs is their capacity for promoting angiogenesis and proangiogenic factor VEGF is the main growth factor for this process that secreted by MSCs during pathophysiological conditions [42, 43].”
BackgroundCalcat-i-Cervera, S., Rendra, E., Scaccia, E., Amadeo, F., Hanson, V., Wilm, B., Murray, P., O’Brien, T., Taylor, A., & Bieback, K. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03352-1 · Cited by 56
“Although our results align with previous studies showing superior proangiogenic abilities [41] and higher secretion of VEGF in BM-MSC cultures [42], others have conversely reported higher tube formation and angiogenic bioactivity in the secretome of A-MSCs [43, 44].”
BackgroundInfluentialPrakash, N., Kim, J., Jeon, J., Kim, S., Arai, Y., Bello, A. B., Park, H., & Lee, S.-H. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00371-0 · Cited by 56
“The immunoregulatory effects of these cells are weaker than those of umbilical cord-derived MSCs (UCMSCs), but their immunomodulatory properties are adequate, and they promote angiogenesis, myogenesis, and growth and development of other cells, which make them a great candidate for cell therapeutics [8, 60, 61].”
BackgroundBudgude, P., Kale, V. P., & Vaidya, A. (2020) · Cryobiology · doi:10.1016/j.cryobiol.2020.11.009 · Cited by 57
The Implications of Microglial Regulation in Neuroplasticity-Dependent Stroke Recovery
Qiao, C., Liu, Z., & Qie, S. (2023) · Biomolecules · doi:10.3390/biom13030571 · Cited by 59
“The injection of human mesenchymal stromal cells (hMSCs) into adult mice has been shown to induce the activation of M2-type microglia [295], which play an important role in functional recovery, angiogenesis, and endogenous neurogenesis [296,297].”
BackgroundTNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties
Beldi, G., Bahiraii, S., Lezin, C., Barkestani, M. N., Abdelgawad, M. E., Uzan, G., & Naserian, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.596831 · Cited by 57
Turano, E., Scambi, I., Virla, F., Bonetti, B., & Mariotti, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032917 · Cited by 56
Castelli, V., Antonucci, I., d’Angelo, M., Tessitore, A., Zelli, V., Benedetti, E., Ferri, C., Desideri, G., Borlongan, C. V., Stuppia, L., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0268 · Cited by 54
Fang, J., Chen, F., Liu, D., Gu, F., & Wang, Y. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01955-6 · Cited by 55
“ADSCs can secrete a variety of extracellular vesicles (EVs), exosomes, and soluble factors [43].”
BackgroundNavarro, L., Chen, X., Viviescas, L. T. G., Ardila-Roa, A. K., Luna-González, M., Sossa, C., & Arango-Rodríguez, M. L. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03043-3 · Cited by 55
Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells
Drzeniek, N. M., Mazzocchi, A. R., Schlickeiser, S., Forsythe, S. D., Moll, G., Geißler, S., Reinke, P., Gossen, M., Gorantla, V. S., Volk, H., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/ac0a32 · Cited by 50
Costa, M. H., Costa, M. S., Painho, B., Sousa, C. D., Carrondo, I., Oltra, E., Pelacho, B., Prósper, F., Isidro, I. A., Alves, P. M., et al. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28378 · Cited by 46
“…on their capacity to release bioactive molecules, such as vascular endothelial growth factor (VEGF), platelet‐derived growth factor (PDGF), and transforming growth factor‐β (TGF‐β), which have been shown to promote modulation of the angiogenic phenotype of endothelial cells (Maacha et al., 2020).”
BackgroundA Narrative Review: Gingival Stem Cells as a Limitless Reservoir for Regenerative Medicine
Fonticoli, L., Rocca, Y. D., Rajan, T. S., Murmura, G., Trubiani, O., Oliva, S., Pizzicannella, J., Marconi, G. D., & Diomede, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084135 · Cited by 44
“In particular, the secretome of MSCs shows regenerative potential similar to MSCs and, consequently, is often used in cell-free tissue regeneration therapies [54].”
BackgroundSekiya, I., Katano, H., Mizuno, M., Koga, H., Masumoto, J., Tomita, M., & Ozeki, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-93462-8 · Cited by 46
Chen, L.-C., Wang, H., & Huang, C. (2021) · Cells · doi:10.3390/cells10102747 · Cited by 42
“MSCs are known to execute therapeutic functions by releasing pro-angiogenic vascular endothelial growth factors and basic fibroblast growth factors, pro-survival hepatocyte growth factors and insulin-like growth factor-1, mitogenic platelet-derived growth factors, and the multifunctional cytokine transforming growth f…”
BackgroundStromal cell identity modulates vascular morphogenesis in a microvasculature-on-a-chip platform
Margolis, E. A., Cleveland, D. S., Kong, Y. P., Beamish, J. A., Wang, W. Y., Baker, B. M., & Putnam, A. J. (2021) · Lab on a Chip · doi:10.1039/d0lc01092h · Cited by 45
Ahmadi, M., Mahmoodi, M., Shoaran, M., Nazari‐Khanamiri, F., & Rezaie, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213974 · Cited by 42
“MSCs can release numerous growth factors and cytokines, such as VEGF, which may promote neovascularization and thus support tumor growth [51,52].”
BackgroundYang, C., Wu, M., You, M., Chen, Y., Luo, M., & Chen, Q. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02158-3 · Cited by 42
Hao, D., Liu, R., Gonzalez‐Fernandez, T., Pivetti, C. D., Jackson, J. E., Kulubya, E. S., Jiang, H.-J., Ju, H.-Y., Liu, W., Panitch, A., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.05.027 · Cited by 44
“Also, the MSC-derived secretome possess strong capabilities in regulating EPCs and ECs for promoting vascularization [61, 62].”
BackgroundAldali, F., Deng, C., Nie, M., & Chen, H. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00235 · Cited by 43
“These vesicles encapsulate a diverse array of bioactive factors, including micro (mi)RNAs, messenger (m)RNA molecules, peptides, proteins, cytokines, and lipids (Harrell et al., 2019; Maacha et al., 2020).”
Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery Disease
Hutchings, G., Kruszyna, Ł., Nawrocki, M. J., Strauss, E., Bryl, R., Spaczyńska, J., Perek, B., Jemielity, M., Mozdziak, P. E., Kempisty, B., et al. (2021) · Antioxidants · doi:10.3390/antiox10050735 · Cited by 39
“The secretome of MSCs contains a range of factors that can aid in angiogenesis, including VEGF and other growth factors, miRNAs and lipids [123].”
BackgroundGorodetsky, R., & Aicher, W. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105302 · Cited by 37
Soler‐Botija, C., Tortajada, M., Munizaga-Larroudé, M., Gálvez‐Montón, C., Bayés‐Genís, A., & Roura, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112683 · Cited by 38
El-Sayed, M. E., Atwa, A., Sofy, A. R., Helmy, Y. A., Amer, K., SEADAWY, A. R., & Bakry, S. (2023) · Histochemistry and Cell Biology · doi:10.1007/s00418-023-02244-y · Cited by 44
“Although these factors play crucial roles in cell recruitment, immune regulation, wound healing, and angiogenesis, rather than in cell lineage (Maacha et al. 2020; Miceli et al. 2021; Peta et al. 2021), there are no up-to-date studies that target the effect of MSCs on wound healing regarding…”
BackgroundHarrell, C. R., Jovicic, B. P., Djonov, V., & Volarević, V. (2020) · Analytical Cellular Pathology · doi:10.1155/2020/1939768 · Cited by 35
“MSC-dependent neovascularization is mainly reliant on the capacity to produce large number of proangiogenic factors (vascular endothelial growth factor (VEGF), HGF, TGF-β, MCP-1, basic fibroblast growth factor, platelet-derived growth factor, angiopoietin-1, placental growth factor, and epidermal growth factor) which…”
BackgroundMesenchymal Stem Cell Spheroids: A Promising Tool for Vascularized Tissue Regeneration
Kang, Y., Na, J., Karima, G., Amirthalingam, S., Hwang, N. S.-Y., & Kim, H. D. (2024) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-024-00636-2 · Cited by 35
“In particular, mesenchymal stem cells (MSCs), whichcandifferentiateintovariouscelltypes,canparticipatein vascularformationthroughdifferentiationintoendothelialcells andsecretingparacrinefactors[6].”
Bryk, M., Karnas, E., Mlost, J., Zuba‐Surma, E. K., & Starowicz, K. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15569 · Cited by 35
Adipose-derived stem cell secretome as a cell-free product for cutaneous wound healing
Ajit, A., & Gopalankutty, I. A. (2021) · 3 Biotech · doi:10.1007/s13205-021-02958-7 · Cited by 35
Current therapeutic strategies for respiratory diseases using mesenchymal stem cells
Wang, M., Zhou, T., Zhang, Z., Liu, H., Zheng, Z., & Xie, H. (2021) · MedComm · doi:10.1002/mco2.74 · Cited by 35
Gallo, A., Cuscino, N., Contino, F., Bulati, M., Pampalone, M., Amico, G., Zito, G., Carcione, C., Centi, C., Bertani, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020863 · Cited by 33
“This phenomenon is probably related to the intrinsic properties of MSCs, which are derived from different sources [9,19].”
BackgroundBone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects
Huang, Y., Zhu, M., Liu, Z., Hu, R., Li, F., Song, Y., Geng, Y., Ma, W., Song, K., & Zhang, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997808 · Cited by 34
“Moreover, BMSCs contributing to angiogenesis at least partly depending on secreting various angiogenic factors includingVEGF, MCP1, interleukin-6, SDF-1a, macrophage colony-stimulating factor, IL-1 receptor, IGF-1, interleukin-8, metalloproteinase 3 (114).”
BackgroundMesenchymal Stem Cells and Their Exocytotic Vesicles
Cai, H., & Guo, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032085 · Cited by 33
de Pedro, M. Á., López, E., González-Nuño, F. M., Pulido, M., Álvarez, V., Marchena, A. M., Preußer, C., Szymanski, W. G., von Strandmann, E. P., Graumann, J., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03413-5 · Cited by 31
“The cellular secretome may be divided into two major components: a soluble fraction, composed of growth factors, cytokines, and other metabolites, and a vesicular fraction to a large extent represented by EVs [10].”
BackgroundSundaram, S., Jensen, T., Roffidal, T., Paquin, K. L., Wanczyk, H., Cockman, M. D., Shadman, S., Finck, C. M., & Fodor, W. L. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-021-00200-9 · Cited by 30
Mesenchymal Stem Cell in Pancreatic Islet Transplantation
Barachini, S., Biso, L., Kolachalam, S., Petrini, I., Maggio, R., Scarselli, M., & Longoni, B. (2023) · Biomedicines · doi:10.3390/biomedicines11051426 · Cited by 30
“The ability of MSCs to communicate with innate and adaptive immune system cells either through direct cell-cell interaction or through their secretome, which contains numerous soluble growth and immunomodulatory factors (microRNA, transfer RNA, long noncoding RNA, growth factors, proteins, and lipids) [9], or via mito…”
BackgroundMesenchymal stem cells for osteoarthritis: Recent advances in related cell therapy
Lin, J., Huang, J., Jiao, Z., Nian, M., Li, C., Dai, Y., Jia, S., & Zhang, X. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10701 · Cited by 29
Functionalized mesenchymal stem cells for enhanced bone regeneration: advances and challenges
Huang, W., Zhou, C., Yu, Y., Qin, S., Chen, L., Lin, H., Zhang, S., Xia, L., & Liang, W. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04699-3 · Cited by 29
Calligaris, M., Zito, G., Busà, R., Bulati, M., Iannolo, G., Gallo, A., Carreca, A. P., Cuscino, N., Castelbuono, S., Carcione, C., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1385712 · Cited by 27
Secretomes as an emerging class of bioactive ingredients for enhanced cosmeceutical applications
Tan, K., Chang, T., & Lin, X. (2022) · Experimental Dermatology · doi:10.1111/exd.14570 · Cited by 26
Ahmed, A. I., Dowidar, M., Negm, A. F., Abdellatif, H., Alanazi, A., Alassiri, M., Samy, W. M., Mekawy, D. M., Abdelghany, E. M. A., El‐naseery, N. I., et al. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01498-x · Cited by 25
“Exploring the paracrine mechanisms through which BM-MSCs modulate ovarian angiogenesis could further sub-stantiate their therapeutic potential in addressing ovarian insufficiency and infertility [81, 82].”
Kavaldzhieva, K., Mladenov, N., Markova, M. D., & Belemezova, K. (2025) · Biomedicines · doi:10.3390/biomedicines13030586 · Cited by 27
“…healing include basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), angiopoietin 1 (ANG-1), placental growth factor (PIGF), interleukin 6 (IL-6), and monocyte chemoattractant protein 1 (MCP-1) [29].”
Mansano, B. S. D. M., da Rocha, V. P., Antônio, E. L., Peron, D. F., de Lima, R. D. N., Tucci, P. J. F., & Serra, A. J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6663539 · Cited by 26
Jeong, H., Choi, D., Oh, Y., Heo, J., & Hong, J. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202102095 · Cited by 25
State of the field: cellular and exosomal therapeutic approaches in vascular regeneration
Tracy, E. P., Stielberg, V., Rowe, G., Benson, D., Nunes, S. S., Hoying, J. B., Murfee, W. L., & LeBlanc, A. J. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00674.2021 · Cited by 23
Shekatkar, M. R., Kheur, S. M., Kharat, A. H., Deshpande, S. S., Sanap, A. P., Kheur, M. G., & Bhonde, R. R. (2022) · Journal of Clinical and Translational Research · doi:10.18053/jctres.08.202204.007 · Cited by 23
The Role of Stem Cells as Therapeutics for Ischaemic Stroke
Ya, J., Pellumbaj, J., Hashmat, A., & Bayraktutan, U. (2024) · Cells · doi:10.3390/cells13020112 · Cited by 25
“Indeed, TNF-α modulates the composition of the MSC secretome [12,50,53], which may influence the endothelial cell migration, differentiation, and proliferation and affect the extent of angiogenesis.”
BackgroundUmbilical cord: an allogenic tissue for potential treatment of COVID-19
Rodriguez, H. C., Gupta, M., Cavazos-Escobar, E., El‐Amin, S. F., & Gupta, A. (2020) · Human Cell · doi:10.1007/s13577-020-00444-5 · Cited by 22
“Immunomodulation by MSCs involves paracrine release of specific cytokines such as TGF-β, interleukin-1 receptor antagonist (IL-1RA), IL-10, IL-4, and IL-13 [7, 44].”
BackgroundLi, Q., Guo, L., Jian, W. A. N. G., Tao, S., & Jin, P. (2023) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(23)60419-4 · Cited by 22
Sano, T., Nakajima, T., Senda, K. A., Nakano, S., Yamato, M., Ikeda, Y., Zeng, H., Kawabe, J.-I., & Matsunaga, Y. T. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03223-1 · Cited by 23
miR-181b promotes angiogenesis and neurological function recovery after ischemic stroke
Xue, L., Shu, L.-Y., Wang, H., Lu, K., Huang, L.-G., Xiang, J.-Y., Geng, Z., Zhao, Y., & Chen, H. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.367957 · Cited by 24
“These findings suggest the therapeutic potential of angiogenesis-related treatments for IS (Maacha et al., 2020).”
Melatonin and Mesenchymal Stem Cells as a Key for Functional Integrity for Liver Cancer Treatment
Elmahallawy, E. K., Mohamed, Y., Abdo, W. S., & Yanai, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124521 · Cited by 22
“However, recent studies showed that paracrine function of MSCs is the main mechanism by which these cells participate in tissue repair [68].”
BackgroundNovel insights for improving the therapeutic safety and efficiency of mesenchymal stromal cells
Najar, M., Martel‐Pelletier, J., Pelletier, J. P., & Fahmi, H. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i12.1474 · Cited by 22
Wszola, M., Nitarska, D., Cywoniuk, P., Gomółka, M., & Klak, M. (2021) · Cells · doi:10.3390/cells10061544 · Cited by 22
Expansion of human mesenchymal stem/stromal cells on temporary liquid microcarriers
Hanga, M. P., Nienow, A. W., Murasiewicz, H., Pacek, A. W., Hewitt, C. J., & Coopman, K. (2020) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.6601 · Cited by 20
Shao, F.-J., Liu, R., Tan, X., Zhang, Q., Ye, L., Yan, B., Zhuang, Y., & Xu, J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s355479 · Cited by 20
Wang, K., Chen, Z., Jin, L., Zhao, L., Meng, L., Kong, F., He, C., Kong, F., Zheng, L., & Liang, F. (2022) · Injury · doi:10.1016/j.injury.2022.09.041 · Cited by 20
Miura, T., Kouno, T., Takano, M., Kuroda, T., Yamamoto, Y., Kusakawa, S., Morioka, M. S., Sugawara, T., Hirai, T., Yasuda, S., et al. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad029 · Cited by 19
“18 Various studies also have reported that MSCs are involved in angiogenesis and are useful in improving different ischemic diseases, such as hindlimb ischemia.”
BackgroundAdvancing diabetes treatment: the role of mesenchymal stem cells in islet transplantation
Mou, L., Wang, T. B., Wang, X., & Pu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1389134 · Cited by 19
Hindle, J., Williams, A., Kim, Y., Kim, D.-S., Patil, K., Khatkar, P., Osgood, Q., Nelson, C., Routenberg, D. A., Howard, M., et al. (2024) · Cells · doi:10.3390/cells13100861 · Cited by 21
Immunomodulatory Actions of Mesenchymal Stromal Cells (MSCs) in Osteoarthritis of the Knee
Babu, G. S., Badrish, Y., Oswal, V. M., Jeyaraman, N., Prajwal, G. S., Jeyaraman, M., Muthu, S., & Khanna, M. (2021) · Osteology · doi:10.3390/osteology1040020 · Cited by 21
“These engrafted MSCs work in a paracrine fashion and stimulate the tissue-specific residual and resilient cells for tissue regeneration and repair [23,24].”
BackgroundWlodarek, L., Alibhai, F. J., Wu, J., Li, S., & Li, R. (2022) · Stem Cells · doi:10.1093/stmcls/sxac019 · Cited by 18
Ekram, S., Khalid, S., Ramzan, F., Salim, A., Bashir, I., Durrieu, M., & Khan, I. (2023) · Cartilage · doi:10.1177/19476035231172154 · Cited by 19
Borkar, R., Wang, X., Zheng, D., Miao, Z., Zhang, Z., Li, E., Wu, Y., & Xu, R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120756 · Cited by 20
Später, T., Assunção, M., Lit, K. K., Gong, G., Wang, X., Chen, Y.-Y., Rao, Y., Li, Y., Yiu, C. H. K., Laschke, M. W., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.03.015 · Cited by 19
“Other functional molecules, previously associated with MSCs, were vastly enriched in MIPSOS, including TSG-6 [21,22], progranulin (GRN) [71], CCN1 [72] and Fig.”
BackgroundInfluentialHassan, N., Hussein, D. M., Malak, F. A., Abdelaziz, M., Boushra, M. I., Shaalan, W., & Elzayat, E. M. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10944-2 · Cited by 17
“…factors (e.g., vascular endothelial growth factor (VEGF), hepatocyte growth fac - tor (HGF), insulin-like growth factor 1 (IGF-1), basic fibroblast growth factor (bFGF)), cytokines (e.g., inter - leukin-10 (IL-10) and transforming growth factor-beta (TGF-β)), and chemokines [ 43, 44, 78, 79].”
Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2
Juárez-Navarro, K. J., Padilla‐Camberos, E., Díaz, N. F., Miranda-Altamirano, A., & Diaz-Martinez, N. E. (2020) · Stem Cells International · doi:10.1155/2020/8892189 · Cited by 17
“Extracellular vesicles (i) Participation in intercellular communication (ii) Carrying of bioactive molecules (GFs, proteins, lipids, miRNAs, tRNA, and lncRNA); this might be involved in angiogenic modulation [45, 46]”
BackgroundLeñero, C., Bowles, A. C., Correa, D., & Kouroupis, D. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.07.005 · Cited by 17
Zhou, T., Rong, M., Wang, Z., Chu, H., Chen, C., Zhang, J., & Tian, Z. (2021) · Cell Proliferation · doi:10.1111/cpr.13129 · Cited by 17
Al‐Dhalimy, A. M. B., Salim, H. M., Shather, A. H., Naser, I. H., Hizam, M. M., & Alshujery, M. K. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154778 · Cited by 17
Arrè, V., Mastrogiacomo, R., Balestra, F., Serino, G., Viti, F., Rizzi, F. R., Curri, M. L., Giannelli, G., Depalo, N., & Scavo, M. P. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040567 · Cited by 19
“MSCs can play a crucial role in mitigating these effects through their paracrine secretion of bioactive molecules [116,117].”
BackgroundHegde, M., Singh, A. K., Kannan, S., Kolkundkar, U., & Seetharam, R. N. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10787-3 · Cited by 18
Tropoelastin Promotes the Formation of Dense, Interconnected Endothelial Networks
Halawani, A. A., Abdulkhalek, L., Mithieux, S. M., & Weiss, A. S. (2021) · Biomolecules · doi:10.3390/biom11091318 · Cited by 17
“There is interest in promoting these paracrine effects to enhance angiogenesis [11].”
BackgroundAtia, G. A. N., Rashed, F., Taher, E. S., Cho, S., Dayem, A. A., Soliman, M. M., Shalaby, H. K., Mohammed, N. A., Taymour, N., El-Sherbiny, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117005 · Cited by 17
Meng, F.-Q., Li, C., Xu, W., Deng, J., Guan, Y.-J., Zhang, T., Yang, B., Zhang, J., Li, X., Han, F., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-22-00311 · Cited by 16
“Angiogenesis is essential for tissue repair and requires an adequate network of blood vessels to supply the injured tissue with blood and growth factors (Caplan and Correa, 2011; Maacha et al., 2020).”
Alvites, R., Branquinho, M., Sousa, A. C., Lopes, B., Sousa, P., Prada, J., Pires, I. C. R., Ronchi, G., Raimondo, S., Luís, A. L., et al. (2022) · Biomolecules · doi:10.3390/biom12060818 · Cited by 19
“Several recent studies have demonstrated that MSCs can act and influence the surrounding environment not only through cell-to-cell interactions but also through paracrine signaling processes [21].”
BackgroundAn Update on Applications of Cattle Mesenchymal Stromal Cells
Merlo, B., Gugole, P. M., & Iacono, E. (2022) · Animals · doi:10.3390/ani12151956 · Cited by 15
Xie, J., Li, X., Zhang, Y., Tang, T., Chen, G., Mao, H., Gu, Z., & Yang, J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00017a · Cited by 15
Metadata
- Authors
- Maacha, S., Sidahmed, H., Jacob, S., Gentilcore, G., Calzone, R., Grivel, J.-C., & Cugno, C.
- Affiliations
- Sidra Medical and Research Center (QA)
- Corresponding author
- Cugno, Chiara
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2020-03-09
- Volume
- 2020
- Pages
- 1-12
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC7085399
- OpenAlex
- W3010082761
- Cited by
- 259
- References
- 132
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 46 · 2023: 39 · 2022: 52 · 2021: 53 · 2020: 12
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Qatar National Research Fund (NPRP12S-0304-190225)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, angiogenesis, paracrine signaling, extracellular vesicles, growth factors, cytokines, cell-free therapy, tissue damage, bone marrow-derived MSCs, adipose-derived MSCs, preconditioning, tissue repair, immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.